Inhibikase Therapeutics (IKT) Provides Safety and Functional

Inhibikase Therapeutics (IKT) Provides Safety and Functional Update on its Phase 1/1b 101 Trial and its Phase 2 IkT-148009 201 Trial

Inhibikase Therapeutics (IKT) Provides Safety and Functional Update on its Phase 1/1b 101 Trial and its Phase 2 IkT-148009 201 Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Atlanta , Georgia , Massachusetts , American , Alex Lobo , Stroy Freeman , Miltonh Werner , Milton Werner , Inhibikase Therapeutics Inc , Facebook , Nasdaq , Exchange Commission , American Academy Of Neurology , Company Contact , Parkinson Progression Marker Initiative , Sternir Inc , Twitter , Youtube , Linkedin , Wall Street , Progression Marker Initiative , Lancet Neurology , American Academy , Inhibikase Director , Non Motor Symptom Score , Abelson Tyrosine Kinase , Ableson Tyrosine , Multiple System Atrophy , Private Securities Litigation Reform Act ,